Jiangong Zhang

National Association of Software & Services Cos. operates as indian information technology and business process outsourcing industry. The company was founded in 1988 and is headquartered in Noida, India.

Technikos LLP (Technikos) is a venture capital firm founded in 2006. The firm is headquartered in London.

Intelligent Ultrasound Ltd. provides ultrasound software solution. Its IQA Audit offers users a comprehensive, independently conducted audit of ultrasound images stored as part of the patient record. The firm's IQA Metrics provides managers and users with metrics, derived from data recorded from the ultrasound equipment during use, to support decision-making. The company was founded by Aris Papageorghiou, Alison Noble and Andrew Hill and is headquartered in Abingdon, the United Kingdom.

First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom.

Deontics Ltd. provides clinical software to process scientific information. It commercializes clinical pathways and clinical decision support systems developed at cancer research UK, oxford university and university college london. The company was founded by John Fox, Guy Wood-Gush and Ioannis Chronakis and is headquartered in London, the United Kingdom.

Oxford Multi Spectral Ltd. manufactures multispectral scanners. The company was founded on March 31, 2011 and is headquartered in Gillingham, the United Kingdom.

Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016.